Accessibility Menu
 
PolyNovo logo

PolyNovo

(ASX) PNV

Current Price$0.93
Market Cap$645.94M
Since IPO (1998)+368%
5 Year-68%
1 Year-5%
1 Month-2%

PolyNovo Financials at a Glance

Market Cap

$645.94M

Revenue (TTM)

$253.51M

Net Income (TTM)

$15.78M

EPS (TTM)

$0.01

P/E Ratio

65.38

Dividend

$0.00

Beta (Volatility)

0.08 (Low)

Price

$0.93

Volume

0

Open

$0.92

Previous Close

$0.93

Daily Range

$0.91 - $0.95

52-Week Range

$0.86 - $1.72

PNV News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About PolyNovo

Industry

Healthcare Equipment and Supplies

Employees

301

CEO

Robyn Elliott, PhD

Headquarters

Port Melbourne, VIC 3207, AU

PNV Financials

Key Financial Metrics (TTM)

Gross Margin

32%

Operating Margin

2%

Net Income Margin

7%

Return on Equity

12%

Return on Capital

3%

Return on Assets

8%

Earnings Yield

1.53%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$645.94M

Shares Outstanding

690.84M

Volume

0

Short Interest

0.00%

Avg. Volume

2.48M

Financials (TTM)

Gross Profit

$122.05M

Operating Income

$4.48M

EBITDA

$10.45M

Operating Cash Flow

$3.15M

Capital Expenditure

$13.93M

Free Cash Flow

$10.78M

Cash & ST Invst.

$33.59M

Total Debt

$17.14M

PolyNovo Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

$70.20M

+48.9%

Gross Profit

$21.46M

+29.3%

Gross Margin

30.57%

N/A

Market Cap

$645.94M

N/A

Market Cap/Employee

$2.29M

N/A

Employees

282

N/A

Net Income

$3.00K

-99.9%

EBITDA

$3.36M

+34.6%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Net Cash

$2.48M

-108.2%

Accounts Receivable

$24.21M

+70.8%

Inventory

$11.85M

+72.1%

Long Term Debt

$28.94M

+111.3%

Short Term Debt

$2.80M

+71.2%

Return on Assets

8.01%

N/A

Return on Invested Capital

2.72%

N/A

Free Cash Flow

$1.62M

-3408.2%

Operating Cash Flow

$9.16M

+688.6%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
PYC.AXPYC Therapeutics Limited
$1.06-4.48%
IMR.AXImricor Medical Systems, Inc.
$1.84-1.60%
IDX.AXIntegral Diagnostics Limited
$2.26+0.44%
OCA.AXOceania Healthcare Limited
$0.57+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
NVDANvidia
$178.10+0.00%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$10.49-0.03%
TQQQProShares Trust - ProShares UltraPro Qqq
$44.15+0.00%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$7.25-0.01%

Questions About PNV

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.